Safe use of efalizumab in a psoriasis patient with chronic heart failure due to hypertrophic cardiomyopathy.
Cassano
N
N
Miracapillo
A
A
Buquicchio
R
R
Mastrandrea
V
V
Vena
G A
GA
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D002312:Cardiomyopathy, Hypertrophic / Q000150:complications*; D002908:Chronic Disease; D005260:Female; D006333:Heart Failure / Q000209:etiology*; D006801:Humans; D008875:Middle Aged; D011565:Psoriasis / Q000150:complications* / Q000188:drug therapy*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C472181:efalizumab